{
    "Trade/Device Name(s)": [
        "ELITech Clinical Systems CHOLESTEROL HDL SL 2G",
        "ELITech Clinical Systems CHOLESTEROL HDL 2G CALIBRATOR",
        "ELITech Clinical Systems CHOLESTEROL LDL SL 2G",
        "ELITech Clinical Systems CHOLESTEROL LDL 2G CALIBRATOR",
        "ELITech Clinical Systems ELITROL I",
        "ELITech Clinical Systems ELITROL II"
    ],
    "Submitter Information": "SEPPIM S.A.S.",
    "510(k) Number": "K103747",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060854",
        "K021316",
        "K971573",
        "K041227"
    ],
    "Regulatory Class": "Class I and Class II",
    "Product Code(s)": [
        "LBS",
        "JIS",
        "JJX"
    ],
    "Summary Letter Date": "August 25, 2011",
    "Summary Letter Received Date": "August 30, 2011",
    "Submission Date": "November 23, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1475",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Lipoprotein test system",
        "Calibrator",
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "High Density Lipoprotein (HDL) Cholesterol",
        "Low Density Lipoprotein (LDL) Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ELITech Clinical Systems Selectra analyzers",
        "Vital Scientific SELECTRA JUNIOR"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic colorimetric test"
    ],
    "Methodologies": [
        "Colorimetric enzymatic assay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ELITech Clinical Systems reagents, calibrators, and controls for HDL and LDL cholesterol determination and quality control using colorimetric enzymatic methods on Selectra analyzers.",
    "Indications for Use Summary": "Intended for quantitative in vitro diagnostic determination of HDL and LDL cholesterol in human serum and plasma and for use as calibrators and controls with ELITech Clinical Systems methods on Selectra analyzers to aid in diagnosis and treatment of lipid disorders, atherosclerosis, and liver/renal diseases.",
    "fda_folder": "Clinical Chemistry"
}